FRANKENMOSQUITO HORROR SHOW UPDATE: Google to Release 64 Million Bacteria-Infected Mosquitoes Across California and Florida Over the Next Two Years
🇺🇸 THE MASSIVE SALE ENDS TONIGHT 🇺🇸
If the bioweaponized tick deployments all across America are not bad enough, then the next round of bioweaponized GMO mosquito releases should certainly make matters far worse for the genetically altered tax slaves, because Google — yes, that very same tech company that was created by the CIA’s venture capital arm In-Q-Tel alongside DARPA as a corporation serving as a coverup “private” front entity for what is in actuality an unconstitutional government sub-agency — is now getting in on the Intelligence-Industrial Complex’s bioterror operations.
So, a CIA/DARPA tech spy company wants to do that which the NWO globopedo’s eugenics errand boy Bill Gates has long been involved in; to wit:
Etc. & etc. & etc.
Yes, the very same Bill Gates that is behind the gain-of-function (GOF) ticks:
This Bill Gates:
And now because this “nonprofit” black ops money laundering genocide puppet is coming under tremendous scrutiny of late, Google is being used as the front company for the continued full spectrum biowarfare being waged against We the People:
Google is seeking federal approval to release up to 64 million specially treated mosquitoes across California and Florida over the next two years, according to an Environmental Protection Agency (EPA) announcement published earlier this month in The Federal Register, the official journal of the U.S. government.
The tech giant is “requesting an experimental use permit (EUP) for the Wolbachia pipientis wAlbB contained in live adult Culex quinquefasciatus male mosquitoes (DQB Strain),” according to the announcement.
A summary of the request reads:
“Google LLC is proposing to use up to 14.080 mg of the active ingredient Wolbachia pipientis wAlbB Contained in Live Adult Culex quinquefasciatus Male Mosquitoes (DQB Strain) for two years in California and Florida. In Florida, up to 16,000,000 DQB Male Mosquitoes are proposed to be released in year 1, and up to 16,000,000 released in year 2. In California, up to 16,000,000 are proposed to be released in year 1, and up to 16,000,000 released in year 2. Proposed testing will include the states of California and Florida to generate data to support a Section 3 product registration application under FIFRA.”
Submit a Comment to the EPA
Since the EPA “has determined that the permit may be of regional and national significance,” the agency is “seeking comments on this application.”
Comments from the public must be received on or before June 5, 2026.
The Federal Register publication explains the process:
“Submit your comments, identified by docket identification (ID) number EPA-HQ-OPP-2025-3951, through the Federal eRulemaking Portal at https://www.regulations.gov. Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. Additional instructions on commenting on and visiting the docket, along with more information about dockets generally, are available at https://www.epa.gov/dockets.”
For further information:
“Each application summary in Unit II. specifies a contact division. The appropriate division contacts are identified as follows: BPPD (Biopesticides and Pollution Prevention Division) (7511M); Shannon Borges; main telephone number: (202) 566-1400; email address: BPPDFRNotices@epa.gov. The mailing address for each contact person is Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-0001. As part of the mailing address, include the contact person’s name, division, and mail code. The division to contact is listed at the end of each application summary.”
The Stated Plan
Google’s “Debug” project rears large numbers of Culex mosquitoes in the laboratory and infects them with a naturally occurring strain of Wolbachia pipientis bacteria.
Wolbachia pipientis is not said to cause direct human infection or disease in humans.
Non-biting males are said to be separated from biting females by using automated sorting systems and released in high volume.
When these Wolbachia-infected males mate with wild female mosquitoes that do not carry the same bacterial strain, a biological mechanism called cytoplasmic incompatibility occurs, causing the fertilized eggs to fail to develop properly.
The stated plan is that, as a result, the next generation of mosquitoes is greatly reduced, gradually suppressing the overall wild population and lowering the transmission of diseases such as West Nile virus, all without chemicals, radiation, or genetic modification of the insects.
Females Can Still Make It Through the Sorting Process
A peer-reviewed 2020 study in BMC Biology warns that the core technology behind the automated systems used to separate male and female mosquitoes is inherently imperfect and risks backfiring.
The paper reveals that “processes for sex-separating mosquitoes are typically error-prone,” even with advanced sorters, and that accidental release of Wolbachia-infected females can trigger “population replacement rather than elimination”—creating biting, Wolbachia-carrying mosquitoes in the wild.
Their stochastic modelling shows that keeping establishment risk below 1% requires an extraordinarily high fidelity (female contamination probability of 10⁻⁶ or better, ideally 10⁻⁷).
That means even a single female in millions of releases could push the risk of permanent Wolbachia establishment across large urban areas like those targeted in Florida and California, turning the project’s intended population suppression into the opposite outcome: widespread biting mosquitoes now carrying the bacteria.
The findings directly undercut claims of near-perfect reliability, especially at the scale of Google’s planned 16–32 million mosquito releases in Florida and California.
Moreover, a 2022 reply paper in Nature Biotechnology from Google’s own Verily/Debug team reveals that the automated systems powering their mosquito releases were still in “prototype or very-early-version stages” during major field trials and continue to need “ongoing iteration and improvement in stability, throughput, and efficiency.”
Wolbachia’s ‘Guaranteed Sterility’ Mechanism Is Not 100% Reliable
When these Wolbachia-infected males mate with wild female mosquitoes that do not carry the same bacterial strain, a biological mechanism called cytoplasmic incompatibility occurs, said to cause the fertilized eggs to fail to develop properly.
But the incompatibility is not biologically infallible.
A 2024 study published in Nature Communications recreated wAlbB’s exact sterility genes in lab mosquitoes and found that 6% to 75% of eggs still produced live embryos in certain mating scenarios.
A 2022 paper in Frontiers in Microbiology—testing the same wAlbB strain Verily uses described the effect as only “nearly complete (98–100%)” cytoplasmic incompatibility, meaning a small but real percentage of eggs can survive.
A 2019 study in PLOS Neglected Tropical Diseases showed that high temperatures (common in Florida and California summers) reduce Wolbachia levels inside mosquitoes and weaken or break the sterility effect entirely.
At the massive scale Google is proposing—millions of mosquitoes released across Florida and California—even a tiny failure rate could let enough eggs hatch to undermine the entire project.
Bottom Line
Millions of bacteria-infected mosquitoes are now being prepared for open-air release over populated American communities under an “experimental use permit,” while the public is expected to simply trust that the sorting systems, sterility mechanisms, and biological containment assumptions will work exactly as promised at massive scale.
But the scientific literature itself shows the systems are not perfect.
Females can make it through the sorting process.
Eggs can still hatch.
Heat can weaken the sterility effect.
And even Google’s own team acknowledged parts of the release infrastructure were still in early-stage development and undergoing continued refinement.
Residents living in the targeted areas never voted for this experiment.
They were never individually asked for informed consent before being turned into participants in a regional biological field trial involving tens of millions of live insects released into the environment.
Once released, these mosquitoes cannot realistically be recalled.
That raises serious questions about informed consent, environmental exposure, public transparency, long-term ecological effects, and whether corporations and government agencies should be permitted to conduct large-scale biological interventions over entire communities before the long-term consequences are fully understood.
People have the right to know exactly what is being released into their environment, what the failure rates are, what happens if the suppression system fails, and who will be held accountable if unintended consequences emerge years later.
It is important to remember that all of these “tech” companies are nothing more than Intelligence-Industrial Complex nodes executing on the unconstitutional (i.e. blatantly illegal) projects of their Federal government agency handlers:
And the depraved rabbit hole goes very deep indeed:
GOF ticks, GMO frankenmosquitos, Modified mRNA slow kill bioweapon “vaccines,” space rockets, social media platforms, online e-commerce, cloud computing, advertising, digital streaming, entertainment and A.I. are all inextricably intertwined and interrelated in this Intelligence-Industrial Complex bioterror and tech crime spree against humanity.
Chances are that if these frankenmosquitos have some sort of disease payloads like malaria, Ivermectin being an endectocide that reduces malaria transmission by killing mosquitoes that feed on treated individuals, has been shown as per recent large-scale trials such as Ivermectin to Control Malaria — A Cluster-Randomized Trial to reduce malaria incidence by at least 26%.
Ivermectin works by making the human host toxic to Anopheles mosquitoes; when a mosquito bites a person who has taken Ivermectin, the insect dies before it can transmit the malaria parasite. This mechanism offers a novel vector-control strategy that is effective against all mosquitoes, even lab-altered ones.
And in terms of these poisonous frankenmosquitos, it’s almost as if wherever Bill Gates and now Google show up, so too does Ivermectin in a kind of garlic to vampire type relationship; in other words, Ivermectin is like Kryptonite to these “Safe and Effective” technocrat eugenicists, which is why applying IverX Cream directly on mosquito and tick bites may very well help reduce itchiness and prevent any GOF disease payloads:
The Ultimate Lyme & Lone Star Diseases Cure & Prophylaxis Protocol
Doxycycline (100mg, 7 days a week for 30-60 days)
Ivermectin (1mg per 1kg body weight, 7 days a week for 30-60 days)
Ivermectin Cream applied topically on the tick and/or mosquito bite
The rest of this protocol may also be beneficial, but not crucial for Lyme and Lone Star:
Tocotrienol and Tocopherol forms (all 8) of Vitamin E (400-800mg per day, 7 days a week). A product called Gamma E by Life Extension or Perfect E are both great.
Bio-Available Curcumin (600mg per day, 2 pills per day 7 days a week). A product called Theracurmin HP by Integrative Therapeutics is bioavailable.
Vitamin D (62.5 mcg [2500 IU] seven days a week).
CBD oil (1-2 droppers full [equal to 167 to 334 mg per day] under the tongue, 7 days a week) CBD-X: The most potent full spectrum organic CBD oil, with 5,000 milligrams of activated cannabinoids and hemp compounds CBD, CBN & CBG per serving.
Fenbendazole (300mg, 7 days a week) or in the case of severe turbo cancers up to 1 gram — for prophylaxis one 150mg tablet once or twice per week
Hydroxychloroquine (10mg/kg/day 7 days a week) - for prophylaxis one 200mg tablet once or twice per week
ImmunX immune support which also greatly increases the bioavailability of both Fenbendazole and Hydroxychloroquine (2 capsules per day) — for prophylaxis 2 capsules per day
Removing sugars and carbohydrates (cancer food) from your diet and replacing table sugar with a zero glycemic index, zero calorie, keto friendly rare sugar like AlluX
Do NOT comply.
Stay tuned for exciting new product launches from RESOLVX HEALTH, which will be coming very soon!
🇺🇸 THE MASSIVE FLASH SALE 🇺🇸 ends tonight, so please use code CREAM25 for 25% off on ALL of the amazing lifesaving products like the Nobel Prize winning miracle compound Ivermectin, the newly released Ivermectin Cream, the no less miraculous Fenbendazole, Hydroxychloroquine, Doxycycline, the full spectrum organic CBD oil containing 5,000 milligrams of activated cannabinoids and hemp compounds CBD, CBN & CBG, the powerful immune support nutraceutical and spike support formula ImmunX, and the sugar craving reducing, blood sugar balancing and even anti-cancer allulose sugar substitute AlluX!
🇺🇸 THE MASSIVE SALE 🇺🇸 ends TONIGHT, May 31st (midnight eastern time), 2026.
Upon adding products to your cart, please go to the cart icon at the top right corner of your browser page and click it, then choose the VIEW CART option whereby you will be redirected to a page where you can enter the code CREAM25 in the Use Coupon Code field.
Only the RESOLVX HEALTH website offers all of the authentic products that this Substack promotes.
Please contact the company directly with any product questions: info@resolvx.health
Hopefully everybody at Giggle got vaxxed.
When you consider that Google is Jewish-owned everything makes sense. Jews are masters of genocide. Russia, Gaza, and now the US.